VELA-101
Asset
- Stage
- Phase 1
- Modality
- Small molecule
- Target
- Lipid and ceramide metabolism
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Hyperlipidemia
Phase 1, Not yet recruiting, NCT07864311, clinicaltrials.gov, 8 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Trials1
- Evidence for its targets1
- Competitors12
- Signals2
Every asset’s record: target, stage, trials and the evidence behind it.